Foley Partner Matt Krueger will join SkinCure Oncology General Counsel and Chief Compliance Officer Ahmed Elganzouri and Advocate Aurora Chief Compliance Office Michelle Frazier to present on “Data Analytics in Health Care Enforcement and Compliance” at an extended session at the 2022 AHLA In-House Counsel Program.
DOJ, HHS OIG, and other agencies increasingly rely on sophisticated data analytics to guide enforcement efforts against health care fraud, waste, and abuse, which increases the need for compliance programs to use data analytics. In this panel, they will discuss:
- Health care enforcement trends and the evolving ways that enforcement agencies use data analytics to guide enforcement efforts
- DOJ’s expectations for compliance programs, including effective use of data
- Practical steps to take to improve use of data in compliance activities, including risk assessments, audits, and investigations
- Challenges to using data effectively, including data availability, technical limitations, and the need to prioritize efforts
To register for the In-House Counsel Program, click here.
People
Related Insights
23 April 2024
Article
The Rubber Meets the Road on State and Federal Vehicle Emissions Strategies
March and April have been busy months for vehicle emission regulation in the U.S. On March 20 and March 29 respectively, the U.S. Environmental Protection Agency issued a set of final emission rules setting stringent emission standards for all vehicle classes.
09 May 2024
Events
The Changing Hospital Landscape
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, is moderating a panel at the 2024 Convergence Forum titled “The Changing Hospital Landscape.”
23 April 2024
Article
U.S. Supreme Court Rules That “Pure Omissions” Are Not Actionable Under Rule 10b-5
On April 12, 2024, the United States Supreme Court delivered an important decision on the issue of whether a failure to make disclosure required under Item 303 of Regulation S-K can support a Rule 10b-5 claim, even in the absence of an otherwise-misleading statement.